持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/07/02 | 3,680 | 3,685 | 3,625 | 3,635 | -45 | -1.2% | 46,300 |
| 2021/07/01 | 3,655 | 3,685 | 3,645 | 3,680 | +40 | +1.1% | 40,600 |
| 2021/06/30 | 3,700 | 3,700 | 3,635 | 3,640 | -45 | -1.2% | 36,000 |
| 2021/06/29 | 3,690 | 3,715 | 3,660 | 3,685 | -55 | -1.5% | 66,300 |
| 2021/06/28 | 3,715 | 3,750 | 3,695 | 3,740 | +55 | +1.5% | 33,600 |
| 2021/06/25 | 3,720 | 3,725 | 3,665 | 3,685 | -35 | -0.9% | 51,900 |
| 2021/06/24 | 3,685 | 3,735 | 3,685 | 3,720 | -5 | -0.1% | 24,800 |
| 2021/06/23 | 3,765 | 3,805 | 3,725 | 3,725 | +20 | +0.5% | 71,000 |
| 2021/06/22 | 3,645 | 3,720 | 3,610 | 3,705 | +130 | +3.6% | 52,900 |
| 2021/06/21 | 3,580 | 3,595 | 3,555 | 3,575 | -15 | -0.4% | 60,700 |
| 2021/06/18 | 3,740 | 3,740 | 3,590 | 3,590 | -115 | -3.1% | 117,300 |
| 2021/06/17 | 3,730 | 3,765 | 3,700 | 3,705 | -10 | -0.3% | 36,200 |
| 2021/06/16 | 3,720 | 3,725 | 3,690 | 3,715 | -25 | -0.7% | 39,900 |
| 2021/06/15 | 3,770 | 3,770 | 3,700 | 3,740 | -10 | -0.3% | 35,100 |
| 2021/06/14 | 3,755 | 3,770 | 3,730 | 3,750 | +10 | +0.3% | 26,700 |
| 2021/06/11 | 3,755 | 3,755 | 3,705 | 3,740 | -5 | -0.1% | 48,200 |
| 2021/06/10 | 3,700 | 3,760 | 3,670 | 3,745 | +45 | +1.2% | 34,300 |
| 2021/06/09 | 3,680 | 3,710 | 3,660 | 3,700 | +35 | +1% | 19,600 |
| 2021/06/08 | 3,635 | 3,685 | 3,635 | 3,665 | +20 | +0.5% | 27,200 |
| 2021/06/07 | 3,660 | 3,660 | 3,625 | 3,645 | +15 | +0.4% | 18,300 |
| 2021/06/04 | 3,610 | 3,640 | 3,610 | 3,630 | -5 | -0.1% | 15,500 |
| 2021/06/03 | 3,585 | 3,650 | 3,585 | 3,635 | +40 | +1.1% | 24,400 |
| 2021/06/02 | 3,590 | 3,630 | 3,560 | 3,595 | -25 | -0.7% | 29,100 |
| 2021/06/01 | 3,585 | 3,620 | 3,560 | 3,620 | +50 | +1.4% | 30,300 |
| 2021/05/31 | 3,630 | 3,660 | 3,555 | 3,570 | -85 | -2.3% | 59,600 |
| 2021/05/28 | 3,650 | 3,660 | 3,605 | 3,655 | +55 | +1.5% | 41,300 |
| 2021/05/27 | 3,655 | 3,680 | 3,595 | 3,600 | -70 | -1.9% | 62,100 |
| 2021/05/26 | 3,695 | 3,695 | 3,650 | 3,670 | -35 | -0.9% | 40,300 |
| 2021/05/25 | 3,700 | 3,725 | 3,685 | 3,705 | -5 | -0.1% | 35,800 |
| 2021/05/24 | 3,730 | 3,745 | 3,710 | 3,710 | -20 | -0.5% | 23,700 |
| 2021/05/21 | 3,750 | 3,750 | 3,710 | 3,730 | -5 | -0.1% | 22,000 |
| 2021/05/20 | 3,720 | 3,745 | 3,715 | 3,735 | +10 | +0.3% | 20,800 |
| 2021/05/19 | 3,700 | 3,750 | 3,690 | 3,725 | -15 | -0.4% | 32,200 |
| 2021/05/18 | 3,735 | 3,750 | 3,690 | 3,740 | +35 | +0.9% | 31,300 |
| 2021/05/17 | 3,705 | 3,750 | 3,680 | 3,705 | -50 | -1.3% | 53,600 |
| 2021/05/14 | 3,770 | 3,845 | 3,725 | 3,755 | +40 | +1.1% | 58,700 |
| 2021/05/13 | 3,780 | 3,820 | 3,715 | 3,715 | -65 | -1.7% | 49,000 |
| 2021/05/12 | 3,810 | 3,835 | 3,770 | 3,780 | -70 | -1.8% | 43,200 |
| 2021/05/11 | 3,900 | 3,940 | 3,840 | 3,850 | -90 | -2.3% | 41,900 |
| 2021/05/10 | 3,840 | 3,940 | 3,840 | 3,940 | +85 | +2.2% | 25,000 |
| 2021/05/07 | 3,875 | 3,900 | 3,855 | 3,855 | ±0 | ±0% | 19,300 |
| 2021/05/06 | 3,850 | 3,935 | 3,850 | 3,855 | +50 | +1.3% | 36,800 |
| 2021/04/30 | 3,830 | 3,870 | 3,805 | 3,805 | -15 | -0.4% | 37,300 |
| 2021/04/28 | 3,880 | 3,890 | 3,820 | 3,820 | -60 | -1.5% | 39,200 |
| 2021/04/27 | 3,935 | 3,940 | 3,880 | 3,880 | -40 | -1% | 32,100 |
| 2021/04/26 | 4,010 | 4,010 | 3,920 | 3,920 | -55 | -1.4% | 25,100 |
| 2021/04/23 | 4,005 | 4,035 | 3,975 | 3,975 | -80 | -2% | 20,500 |
| 2021/04/22 | 4,015 | 4,065 | 4,015 | 4,055 | +75 | +1.9% | 45,400 |
| 2021/04/21 | 3,980 | 4,020 | 3,955 | 3,980 | -35 | -0.9% | 45,800 |
| 2021/04/20 | 4,050 | 4,055 | 4,000 | 4,015 | -35 | -0.9% | 44,100 |
951～
1000
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
